Back to homepage

Dermatology

Mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL) epidemiology and treatment pathway in Spain: new insights for an accurate description

Authors: Paolo D’Agostino MSc, Alan Kent BSc (Hons), Eric Sharp MRSB, Fabian Schmidt Dipl.Kfm, Marco Turini MSc

This study aims to (1) provide an estimate for the prevalence of treated mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL) patients in Spain, (2) describe the Spanish patient treatment pathways for MF-CTCL, including quantification of the distribution of patients between primary, secondary and tertiary care institutions, and (3) investigate and quantify the treatment preferences of physicians.

More

Tinea corporis: an updated review

Authors: Alexander KC Leung MBBS, FRCPC, FRCP (UK and Irel), FRCPCH, FAAP, Joseph M Lam MD, FRCPC, Kin Fon Leong MBBS, MRCPCH, Kam Lun Hon MD, FAAP, FCCM

This article provides a narrative updated review on the evaluation, diagnosis, and treatment of tinea corporis.

More

Hydroxychloroquine-induced hyperpigmentation in a 14-year-old female with systemic lupus erythematosus

Authors: Alexander KC Leung MBBS, FRCP (UK & Irel), FRCPCH, FAAP, Tara McMillan MD, FRCPC, Andrea Human MD, FRCPC, Joseph M Lam MD, FRCPC

Physicians who use hydroxychloroquine in children should be aware of this less-known side effect of hydroxychloroquine so that an accurate diagnosis can be made, and unnecessary investigations and inappropriate treatment can be avoided.

More

Topical treatment of radiation-induced dermatitis: current issues and potential solutions

Authors: Nicola Alessandro Iacovelli MD, Yvan Torrente MD, PhD, Adriana Ciuffreda MD, Vittorio A Guardamagna MD, PhD, Marta Gentili MS, Luca Giacomelli PhD, Paola Sacerdote PhD

The aim of this paper is to discuss current knowledge on radiation-induced dermatitis and propose targets for the prevention/treatment of this
condition. On these bases, the characteristics of the ‘ideal’
compound to address this side effect will be described.

More

Temozolomide and oral etoposide in children with recurrent malignant brain tumors

Authors: Antonio Ruggiero MD, Anna Ariano MD, Silvia Triarico MD, Michele Antonio Capozza MD, Alberto Romano MD, Palma Maurizi MD, Stefano Mastrangelo MD, Giorgio Attinà MD

The article reviews the results
derived from the combination use of TMZ and oral VP-16 to treat malignant brain tumors

More